JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.12% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Dolby
DLB
$5.84B
| $4.2M | ﹤0.01% |
61,081
-113,577
| -65% | -$7.51M |
|
2702
Dillards
DDS
$9.93B
| $4.2M | ﹤0.01% |
57,182
+33,194
| +138% | +$2.35M |
|
2703
PUT
Trip.com Group
TCOM
$28.3B
| $4.19M | ﹤0.01% |
125,000
| – | – |
|
2704
Lattice Semiconductor
LSCC
$18.4B
| $4.18M | ﹤0.01% |
218,586
+22,297
| +11% | +$428K |
|
|
SWN
2705
DELISTED
Southwestern Energy Company
SWN
| $4.17M | ﹤0.01% |
1,722,575
-328,105
| -16% | -$678K |
|
2706
uniQure
QURE
$3.26B
| $4.17M | ﹤0.01% |
58,157
-57,726
| -50% | -$3.17M |
|
2707
Chemours
CC
$2.29B
| $4.16M | ﹤0.01% |
230,163
-590,070
| -72% | -$9.8M |
|
2708
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $4.16M | ﹤0.01% |
133,390
-71,056
| -35% | -$2.14M |
|
2709
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
| $4.16M | ﹤0.01% |
141,936
-616,003
| -81% | -$16.8M |
|
2710
Mattel
MAT
$4.25B
| $4.15M | ﹤0.01% |
306,536
-37,954
| -11% | -$450K |
|
2711
CALL
Lennar Class A
LEN
$21.1B
| $4.15M | ﹤0.01% |
76,855
-103,300
| -57% | -$5.89M |
|
|
AVTR.PRA
2712
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $4.15M | ﹤0.01% |
65,907
-168,807
| -72% | -$9.63M |
|
2713
PUT
NetEase
NTES
$78.5B
| $4.14M | ﹤0.01% |
67,500
-17,500
| -21% | -$1.03M |
|
2714
CALL
Boston Scientific
BSX
$74.9B
| $4.14M | ﹤0.01% |
91,500
+18,200
| +25% | +$762K |
|
|
ARA
2715
DELISTED
American Renal Associates Holdings, Inc
ARA
| $4.14M | ﹤0.01% |
398,762
-207,054
| -34% | -$1.77M |
|
2716
ATI
ATI
$31.4B
| $4.12M | ﹤0.01% |
199,612
-6,853
| -3% | -$149K |
|
2717
PUT
Golar LNG
GLNG
$5.21B
| $4.12M | ﹤0.01% |
+290,000
| New | +$3.93M |
|
2718
Arcosa
ACA
$7.12B
| $4.12M | ﹤0.01% |
92,409
-1,167
| -1% | -$44.9K |
|
|
WAAS
2719
DELISTED
AquaVenture Holdings Limited
WAAS
| $4.08M | ﹤0.01% |
150,231
+145,634
| +3,168% | +$3.09M |
|
2720
Nu Skin
NUS
$236M
| $4.07M | ﹤0.01% |
99,444
-38,812
| -28% | -$1.58M |
|
2721
iShares Core US REIT ETF
USRT
$4.63B
| $4.07M | ﹤0.01% |
74,521
+4,911
| +7% | +$270K |
|
|
BPMC
2722
CALL
DELISTED
Blueprint Medicines
BPMC
| $4.05M | ﹤0.01% |
+50,600
| New | +$3.79M |
|
2723
Sanofi
SNY
$105B
| $4.05M | ﹤0.01% |
80,746
+37,265
| +86% | +$1.75M |
|
|
RPT
2724
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.04M | ﹤0.01% |
268,886
+66,138
| +33% | +$944K |
|
2725
International Bancshares
IBOC
$4.52B
| $4.04M | ﹤0.01% |
93,856
-30,544
| -25% | -$1.27M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.